Insider Trading Activity For United Cannabis Corp (NASDAQ:CNAB)
Tony Verzura , VP of United Cannabis Corp (NASDAQ:CNAB) reportedly Sold 46,980 shares of the company’s stock at an average price of 1.06 for a total transaction amount of $49,798.80 SEC Form
Analyst Ratings For United Cannabis Corp (NASDAQ:CNAB)
These are No ratings tracked in the last 12 months.The current consensus rating for United Cannabis Corp (NASDAQ:CNAB) is N/A (Score: NaN) with a consensus target price of N/A
About United Cannabis Corp (NASDAQ:CNAB)
United Cannabis Corporation is engaged in medical spa management business. The Company focuses on providing products, services and intellectual property to the cannabis industry. It owns intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products. The Company focuses on advancing the use of phytocannabinoid therapeutics in medicine through research, product development and education. The Company’s ACT Now Program utilizes its Prana Bio Nutrient Medicinals with a Health Insurance Portability and Accountability Act (HIPAA) of 1996 compliant electronic health record (EHR) software that enables physicians to create sequencing charts specific to their patients’ medical aliments. The ACT Now EHR software allows for global monitoring, patient management and cannabinoid therapy protocols. It offers consulting and training services.
Recent Trading Activity for United Cannabis Corp (NASDAQ:CNAB)
Shares of United Cannabis Corp closed the previous trading session at 1.09 0.00 0.00% with 29,418 shares trading hands.